Empresas › ADmit Therapeutics SL

ADmit Therapeutics SL

🇪🇸 Sant Feliu de Llobregat (Barcelona), Spain · Hall 1 / D33 · Expositor principal · MEDICA 2026

Contacto

🌐 https://www.admit-therapeutics.com
✉️ info@admit-therapeutics.com
📞 +34 93 1088001
Ctra. Laurea Miro 408-410, 08980, Sant Feliu de Llobregat (Barcelona)
linkedin
Perfil oficial ↗ · canónico ↗

Stands

12 m²1 stand(s)
Hall 1 / D33

Relaciones

—

Descripción

ADmit Therapeutics** is a biotech company founded in Barcelona as a spin-off of the Bellvitge Biomedical Research Institute (IDIBELL). The company specializes in early diagnostic and prognostic solutions for neurodegenerative conditions, focusing primarily on Alzheimer’s disease.


ADmit Therapeutics developed the MAP-AD® test, a proprietary, non-invasive technology that uses blood samples to analyze epigenetic biomarkers—specifically mitochondrial DNA methylation patterns—combined with machine learning algorithms. This novel mechanism enables healthcare providers to predict progression to Alzheimer's dementia in patients with mild cognitive impairment well before severe symptoms occur.


By advancing precision medicine and transforming clinical patient management, ADmit Therapeutics aims to streamline early interventions and optimize patient selection for pharmaceutical clinical trials worldwide.

Stands y superficie

StandHallSuperficieDimensionesMétodoConfianzaComparten
D33Hall 112 m²
geom. bruta 10,7
3 × 4 mrectangle_grid_snapped(hall_calibrated,large_scale_correction)🟡 media1
Ubicación en Hall 1 (en rojo):
E56 · 28 m²E56B44 · 20 m²D24 · 35 m²D24D43 · 63 m²D43D32 · 64 m²D32D26 · 30 m²D26B07 · 25 m²C44 · 24 m²A11 · 50 m²A11B18 · 40 m²B18D15 · 90 m²D15D07 · 12 m²E59 · 36 m²E59E57 · 36 m²E57D66 · 15 m²B65 · 36 m²B65F02 · 12 m²E43 · 24 m²D03 · 72 m²D03E53 · 18 m²D35 · 12 m²D58 · 30 m²D58B10 · 24 m²F33 · 12 m²F16 · 18 m²B05 · 15 m²E24 · 18 m²A63 · 42 m²A63A57 · 24 m²A65 · 48 m²A65B63 · 24 m²A01 · 12 m²A49 · 60 m²A49G50 · 24 m²A17 · 24 m²D68 · 12 m²D25 · 50 m²D25D11 · 15 m²G62 · 12 m²B37 · 18 m²D46 · 24 m²D18 · 49 m²D18B57 · 36 m²B57F63 · 15 m²C38 · 18 m²F50 · 21 m²B06 · 35 m²B06H66 · 12 m²D63 · 48 m²D63D01 · 24 m²E34 · 24 m²F45 · 12 m²A10 · 33 m²A10F23-7 · 12 m²F23-5 · 9 m²F11-3 · 6 m²F23-1 · 9 m²F23-8 · 12 m²F23-2 · 9 m²F23-4 · 21 m²H10-23 · 15 m²H10-1 · 15 m²H10-3 · 39 m²H10-3F15-5 · 9 m²F15-1 · 15 m²F15-8 · 9 m²F15-4 · 9 m²F15-2 · 6 m²F11-4 · 6 m²F11-1 · 16 m²B25 · 36 m²B25A33 · 16 m²B72 · 12 m²E18 · 21 m²A09 · 36 m²A09D04 · 35 m²D04C37 · 12 m²A39 · 12 m²B33 · 12 m²D45 · 24 m²B39 · 21 m²D05 · 18 m²B64 · 20 m²E63 · 36 m²E63B31 · 32 m²B31B43 · 15 m²B66 · 12 m²F59 · 21 m²B09 · 16 m²E39 · 12 m²G64 · 12 m²B56 · 30 m²B56A23 · 21 m²D37 · 28 m²D37D49 · 32 m²D49B15 · 100 m²B15D17 · 28 m²D17H67 · 15 m²D08 · 30 m²D08E32 · 16 m²B45 · 48 m²B45B17 · 24 m²D39 · 45 m²D39D50 · 32 m²D50D52 · 36 m²D52G56 · 72 m²G56F31 · 84 m²F31E10 · 12 m²D23 · 28 m²D23B34 · 16 m²C43 · 24 m²A25 · 50 m²A25E31 · 24 m²D40 · 18 m²A31 · 70 m²A31B08 · 24 m²B49 · 32 m²B49D70 · 12 m²B02 · 24 m²B23 · 42 m²B23E49 · 24 m²D10 · 28 m²D10F42 · 12 m²H69 · 15 m²F51 · 24 m²D64 · 36 m²D64A43 · 16 m²E09 · 18 m²F52 · 18 m²D38 · 15 m²C34 · 12 m²B59 · 12 m²G36 · 36 m²G36G38 · 72 m²G38G39 · 72 m²G39H39 · 66 m²H39G49 · 72 m²G49G53 · 72 m²G53G63 · 72 m²G63H57 · 36 m²H57H63 · 24 m²A15 · 30 m²A15A37 · 24 m²E46 · 12 m²D57 · 35 m²D57A59 · 18 m²B40 · 28 m²B40E11 · 24 m²C40 · 12 m²G32 · 12 m²D59 · 24 m²B61 · 12 m²E58 · 12 m²C39 · 12 m²B03 · 24 m²D51 · 20 m²D34 · 15 m²E41 · 12 m²E25 · 54 m²E25D44 · 18 m²E26 · 40 m²E26D33 · 12 m²E33 · 12 m²E37 · 12 m²D56 · 18 m²E08 · 15 m²B38 · 24 m²E07 · 15 m²B58 · 20 m²F34 · 12 m²F38 · 12 m²B24 · 18 m²E48 · 35 m²E48B51 · 36 m²B51F46 · 12 m²G46 · 12 m²E52 · 20 m²A41 · 12 m²E38 · 20 m²C33 · 12 m²E17 · 24 m²F24 · 21 m²E45 · 12 m²G37 · 150 m²G37E62 · 24 m²F40 · 12 m²F08 · 18 m²A05 · 21 m²B69 · 12 m²A21 · 20 m²E06 · 12 m²F18 · 21 m²G58 · 12 m²E23 · 18 m²A03 · 12 m²B46 · 12 m²A45 · 18 m²A47 · 40 m²A47A46 · 15 m²F66 · 153 m²F66F04 · 18 m²H01 · 69 m²H01E15 · 18 m²

Categorías

01.02.02.02 · Next-generation sequencing (NGS)

Productos (1)

MAP-AD-Pioneering-Precision-Medicine-and-Prognosis-in-Alzheimers-Disease
Next-generation sequencing (NGS)

Documentos y vídeos

📄 Flyer_MAP_AD
📄 MAP-AD-Pioneering-Precision-Medicine-and-Prognosis-in-Alzheimers-Disease_Onepager
Linaje y fuentes (6 respuestas originales · 0 capturas)
ObjetoURL de origenDescargado (UTC)SHA-256R2
floorplan_module
#11 · HTTP 200
https://floorplan.medica-tradefair.com/medica2026/Exhibitors/exhibitors_module.js2026-11-15 11:29:5929fce4447dd85490…raw
directory
#53 · HTTP 200
https://www.medica-tradefair.com/vis-api/vis/v1/en/directory/a2026-11-15 11:30:2063525c4273919be2…raw
profile
#5146 · HTTP 200
https://www.medica-tradefair.com/vis-api/vis/v1/en/exhibitors/medica2026.3076901/slices/profile2026-11-15 11:43:37f35c0a597baa33c0…raw
contacts
#5150 · HTTP 200
https://www.medica-tradefair.com/vis-api/vis/v1/en/exhibitors/medica2026.3076901/slices/contacts?parentModule=profile&parentModule=stand2026-11-15 11:43:384f53cda18c2baa0c…raw
products
#5154 · HTTP 200
https://www.medica-tradefair.com/vis-api/vis/v1/en/exhibitors/medica2026.3076901/slices/products2026-11-15 11:43:38d8cc59f424eb0844…raw
appointments
#5157 · HTTP 200
https://www.medica-tradefair.com/vis-api/vis/v1/en/exhibitors/medica2026.3076901/slices/appointments2026-11-15 11:43:396d1df4a3a8326b2a…raw